ARM DCF Suggests $17 Intrinsic Value vs. $211 Price: DeepValue Report Maintains WAIT

What happened

A GuruFocus DCF analysis on May 4, 2026 valued Arm Holdings at $17 per share, a fraction of its ~$125 trading price, flagging extreme overvaluation under conservative assumptions. The DeepValue Master Report, based on the 2025 20-F and Q3 FY26 results, rates Arm a WAIT with a base case of $130, citing robust recent growth (+26% YoY revenue) but noting P/E of 166x and EV/EBITDA of 145x leave no margin of safety. The report's bear case is $95 and bull case $170, with the DCF implying over 85% downside even from the bear case. The divergence stems from differing long-term growth and margin assumptions: the report relies on CSS commercialization and server share gains to sustain 15-25% royalty growth, while the DCF likely applies more conservative terminal growth and discount rates. The key tension is between near-term momentum and extreme valuation; the report's attractive entry at $110 offers a 12% downside but still far above the DCF's $17.

Implication

The massive gap between the DCF estimate and the report's scenarios underscores extreme valuation risk. Investors should demand sustained growth acceleration (royalties +20%+ YoY, ACV +20%+ YoY) and be prepared for severe multiple compression if any quarter disappoints. The DCF forces a rethink of terminal value; if the market begins to adopt similar long-term assumptions, the stock could see significant downside. Until then, the WAIT rating with a trim above $155 and entry at $110 remains appropriate, but the risk-reward has shifted to the downside.

Thesis delta

The DCF analysis challenges the core thesis by implying Arm is dramatically overvalued even relative to the report's bear case of $95. While the report's base case sees growth sustaining $130, the DCF forces a reassessment of terminal value assumptions and growth sustainability. The margin of safety is now even thinner than the report's WAIT rating suggested; the stock's risk-reward is skewed to the downside unless quarterly results consistently exceed expectations and validate the premium multiple.